InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Schimmelpennink Evert B.. Officer active across 1 company, notably LENZ Therapeutics, Inc.. In total, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €218k. Activity tracked since 22 July 2024. The latest transaction was disclosed on 27 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations